ConductScience.org, home

Trial · NCT00643760

Outcomes19

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

TypeOutcomeTime framePopulationUnitsMeasured as
PRIMARYChange From Baseline in the Mean 24-hour Average Pain Intensity (API) Score at End of Maintenance Treatment (EOMT) Using Last Observation Carried Forward (LOCF) DataBaseline and EOMT (representing the earliest date of Week 13 visit/withdrawal visit)ITT Populationscores on a scaleLEAST_SQUARES_MEAN
SECONDARYChange From Baseline in the Mean Day-time Average Pain Intensity (API) Score at EOMT Using LOCF DataBaseline and EOMT (representing the earliest date of Week 13 visit/withdrawal visit)ITT Populationscores on a scaleLEAST_SQUARES_MEAN
SECONDARYChange From Baseline in the Mean Night-time Average Pain Intensity (API) Score at EOMT Using LOCF DataBaseline and EOMT (representing the earliest date of Week 13 visit/withdrawal visit)
ITT Population. There were two participants in the GEn 3600 mg/day group who did not complete enough post-baseline morning diaries to calculate an average night-time pain intensity score for the EOMT timepoint.
scores on a scaleLEAST_SQUARES_MEAN
SECONDARYChange From Baseline in the Mean Current (Morning) Pain Intensity Score at EOMT Using LOCF DataBaseline and EOMT (representing the earliest date of Week 13 visit/withdrawal visit)
ITT Population. There were two participants in the GEn 3600 mg/day group who did not complete enough post-baseline morning diaries to calculate a current (morning) pain intensity score for the EOMT timepoint.
scores on a scaleLEAST_SQUARES_MEAN
SECONDARYChange From Baseline in the Mean Current (Evening) Pain Intensity Score at EOMT Using LOCF DataBaseline and EOMT (representing the earliest date of Week 13 visit/withdrawal visit)ITT Populationscores on a scaleLEAST_SQUARES_MEAN
SECONDARYChange From Baseline in the Mean Day-time Worst Pain Intensity Score at EOMT Using LOCF DataBaseline and EOMT (representing the earliest date of Week 13 visit/withdrawal visit)ITT Populationscores on a scaleLEAST_SQUARES_MEAN
SECONDARYChange From Baseline in the Mean Night-time Worst Pain Intensity Score at EOMT Using LOCF DataBaseline and EOMT (representing the earliest date of Week 13 visit/withdrawal visit)
ITT Population. There were two participants in the GEn 3600 mg/day group who did not complete enough post-baseline morning diaries to calculate a night-time worst pain intensity score for the EOMT timepoint.
scores on a scaleLEAST_SQUARES_MEAN
SECONDARYChange From Baseline in the Mean Sleep Interference Score at EOMT Using LOCF DataBaseline and EOMT (representing the earliest date of Week 13 visit/withdrawal visit)
ITT Population. There were two participants in the GEn 3600 mg/day group who did not complete enough post-baseline morning diaries to calculate a night-time worst pain intensity score for the EOMT timepoint.
scores on a scaleLEAST_SQUARES_MEAN
SECONDARYChange From Baseline in the Mean Daily Dose of Rescue Medication at EOMT Using LOCF DataBaseline and EOMT (representing the earliest date of Week 13 visit/withdrawal visit)ITT PopulationmilligramsLEAST_SQUARES_MEAN
SECONDARYChange From Baseline in Pain Quality as Assessed by the Neuropathic Pain Scale (NPS) Summary Scores at EOMT Using LOCF DataBaseline and EOMT (representing the earliest date of Week 13 visit/withdrawal visit)ITT Population. Not all participants completed an NPS assessment at both Baseline and Week 13/Withdrawal; as such, the number analyzed is different from the full ITT Population counts.scores on a scaleLEAST_SQUARES_MEAN
SECONDARYChange From Baseline in Pain Characteristics and Intensity as Assessed by the Short Form-McGill Pain Questionnaire (SF-MPQ) at EOMT Using LOCF DataBaseline and EOMT (representing the earliest date of Week 13 visit/withdrawal visit)ITT Population. Not all participants completed an SF-MPQ assessment at both Baseline and Week 13/Withdrawal; as such, the number analyzed is different from the full ITT Population counts.scores on a scaleLEAST_SQUARES_MEAN
SECONDARYChange From Baseline in Pain Score After Taking a 50-foot Walk at EOMTBaseline and EOMT (representing the earliest date of Week 13 visit/withdrawal visit)ITT Population. Not all participants completed a 50-foot walk at both Baseline and Week 13/Withdrawal; as such, the number analyzed is different from the full ITT Population counts.scores on a scaleLEAST_SQUARES_MEAN
SECONDARYNumber of Participants Who Are Responders on the Patient Global Impression of Change (PGIC) Questionnaire at EOMT Using LOCF DataEOMT (representing the earliest date of Week 13 visit/withdrawal visit)ITT Population. Not all participants completed a PGIC assessment at Week 13/Withdrawal; as such, the number analyzed is different from the full ITT Population counts.participantsNUMBER
SECONDARYNumber of Participants Who Are Responders on the Clinician Global Impression of Change (CGIC) Questionnaire at EOMT Using LOCF DataEOMT (representing the earliest date of Week 13 visit/withdrawal visit)ITT Population. Not all participants had a CGIC assessment at Week 13/Withdrawal; as such, the number analyzed is different from the full ITT Population counts.participantsNUMBER
SECONDARYNumber of Participants Achieving Various Levels of Percent Reduction From Baseline in the Mean 24-hour Average Pain Intensity Score at EOMT Using LOCF DataBaseline and EOMT (representing the earliest date of Week 13 visit/withdrawal visit)ITT PopulationparticipantsNUMBER
SECONDARYTime to Onset of Sustained Improvement in the 24-hour Average Pain Intensity ScoreAny time post-baseline until date of last dose of study medication (up to Week 13)ITT PopulationdaysMEDIAN
SECONDARYChange From Baseline in Severity of Pain and the Impact of Pain as Assessed by the Brief Pain Inventory (BPI) at EOMT Using LOCF DataBaseline and EOMTITT Population. Not all participants completed a BPI assessment at both Baseline and Week 13/Withdrawal; as such, the number analyzed is different from the full ITT Population counts.scores on a scaleLEAST_SQUARES_MEAN
SECONDARYChange From Baseline in Quality of Life as Assessed by the 36-Item Short Form Health Survey (SF-36) at EOMT Using LOCF DataBaseline and EOMT (representing the earliest date of Week 13 visit/withdrawal visit)ITT Population. Not all participants completed an SF-36 at both Baseline and Week 13/Withdrawal; as such, the number analyzed is different from the full ITT Population counts.scores on a scaleLEAST_SQUARES_MEAN
SECONDARYChange From Baseline in Emotional Functioning as Assessed by the Profile of Mood States-Brief Form (POMS-B) at EOMT Using LOCF DataBaseline and EOMT (representing the earliest date of Week 13 visit/withdrawal visit)ITT Population. Not all participants completed a POMS-B at both Baseline and Week 13/Withdrawal; as such, the number analyzed is different from the full ITT Population counts.scores on a scaleLEAST_SQUARES_MEAN

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00643760/outcomes